NASDAQ: FEMYFemasys Inc Stock Ownership - Who owns Femasys?
Insider buying vs selling
Have Femasys Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Charles Canning | COO | 2026-08-07 | 4,375 | $3.20 | $14.00kBuy |
| Dov Elefant | CFO | 2026-08-07 | 15,625 | $3.20 | $50.00kBuy |
| Kathy Leesepsick | CEO | 2026-08-07 | 15,625 | $3.20 | $50.00kBuy |
| Jeffrey Gerald Mifek | CXO | 2026-08-07 | 3,125 | $3.20 | $10.00kBuy |
| Jeremy Alexander Sipos | CTO | 2026-08-07 | 3,125 | $3.20 | $10.00kBuy |
FEMY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when FEMY insiders and whales buy or sell their stock.
FEMY Shareholders
What type of owners hold Femasys Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Edward R. Uzialko | 14.54% | 1,217,406 | $3.73M | Insider |
| John Dyett | 3.50% | 292,844 | $896.10k | Insider |
| John Q. Adams Jr. | 2.86% | 239,938 | $734.21k | Insider |
| Daniel Scott Currie | 1.30% | 109,240 | $334.27k | Insider |
| Kathy Leesepsick | 1.05% | 87,848 | $268.81k | Insider |
| Kenneth D. Eichenbaum | 0.30% | 25,010 | $76.53k | Insider |
| Dov Elefant | 0.19% | 15,625 | $47.81k | Insider |
| William Benson Witte | 0.15% | 12,191 | $37.30k | Insider |
| John Charles Canning | 0.05% | 4,375 | $13.39k | Insider |
| Gary Thompson | 0.04% | 3,334 | $10.20k | Insider |
FEMY vs Medical Stocks
Femasys Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.